Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Clinical trial NCT06128070 · RECRUITING

Trial details

NCT number

NCT06128070

Sponsor

City of Hope Medical Center

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2024-07-16

Primary completion

2030-11-22

Enrollment

40

View on ClinicalTrials.gov